Recent News

• 04.15.2025 - Repligen to Report First Quarter 2025 Financial Results
• 04.08.2025 - Repligen Appoints Jacob Johnson As Vice President Investor Relations
• 03.04.2025 - Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

Recent Filings

• 04.04.2025 - DEF 14A Other definitive proxy statements
• 04.04.2025 - ARS Annual Report to Security Holders
• 04.04.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.17.2025 - PRE 14A Other preliminary proxy statements
• 03.17.2025 - 144 Report of proposed sale of securities
• 03.14.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]